Search Login Register

cefcanel daloxate (KY 109) Summary

4 relevant articles (2 outcomes, 2 trials/studies) found for this Bio-Agent

Description: pro-drug to improve oral absorption of KY-087; structure given in first source

Also Known As: KY 109; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl-7(O-(alanyl)mandelamido)-3-((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl-3-cephem-4-carboxylate hydrochloride; KY-109; L-Alanine, 2-((2-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)amino)-2-oxo-1-phenylethyl ester, monohydrochloride, (6R-(6alpha,7beta(R*)))-

Key Diseases for which cefcanel daloxate is Relevant

  1. Urinary Tract Infections (Urinary Tract Infection) : 1 outcome 1 study in 1 result
  2. Infection : 1 outcome in 1 result
  3. Granuloma : 1 outcome in 1 result
  4. Renal Insufficiency : 1 study in 1 result
  5. Maxillary Sinusitis : 1 result

Drugs Related to cefcanel daloxate

  1. Amoxicillin (Wymox)
  2. cefcanel
  3. Cefaclor (Ceclor)

Therapies Related to cefcanel daloxate


CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.